99 related articles for article (PubMed ID: 29664675)
1. Knockout of glucose transporter GLUT6 has minimal effects on whole body metabolic physiology in mice.
Byrne FL; Olzomer EM; Brink R; Hoehn KL
Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E286-E293. PubMed ID: 29664675
[TBL] [Abstract][Full Text] [Related]
2. Investigating the Expression and Function of the Glucose Transporter GLUT6 in Obesity.
Chen SY; Olzomer EM; Beretta M; Cantley J; Nunemaker CS; Hoehn KL; Byrne FL
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077188
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Glucose Transporter 6 in Lipopolysaccharide-Induced Bone Marrow-Derived Macrophage Function.
Caruana BT; Byrne FL; Knights AJ; Quinlan KGR; Hoehn KL
J Immunol; 2019 Mar; 202(6):1826-1832. PubMed ID: 30700586
[TBL] [Abstract][Full Text] [Related]
4. Pappa2 deletion alters IGFBPs but has little effect on glucose disposal or adiposity.
Christians JK; Bath AK; Amiri N
Growth Horm IGF Res; 2015 Oct; 25(5):232-9. PubMed ID: 26164771
[TBL] [Abstract][Full Text] [Related]
5. The NF-κB signalling pathway regulates GLUT6 expression in endometrial cancer.
Caruana BT; Byrne FL
Cell Signal; 2020 Sep; 73():109688. PubMed ID: 32512041
[TBL] [Abstract][Full Text] [Related]
6. GLUT6 is a lysosomal transporter that is regulated by inflammatory stimuli and modulates glycolysis in macrophages.
Maedera S; Mizuno T; Ishiguro H; Ito T; Soga T; Kusuhara H
FEBS Lett; 2019 Jan; 593(2):195-208. PubMed ID: 30431159
[TBL] [Abstract][Full Text] [Related]
7. Loss of CTRP1 disrupts glucose and lipid homeostasis.
Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor deficiency in monocytes/macrophages does not alter adiposity or glucose homeostasis in male mice.
Rubinow KB; Houston B; Wang S; Goodspeed L; Ogimoto K; Morton GJ; McCarty C; Braun RE; Page ST
Asian J Androl; 2018; 20(3):276-283. PubMed ID: 29205180
[TBL] [Abstract][Full Text] [Related]
9. Female mice target deleted for the neuromedin B receptor have partial resistance to diet-induced obesity.
Paula GS; Souza LL; Cabanelas A; Bloise FF; Mello-Coelho V; Wada E; Ortiga-Carvalho TM; Oliveira KJ; Pazos-Moura CC
J Physiol; 2010 May; 588(Pt 9):1635-45. PubMed ID: 20211980
[TBL] [Abstract][Full Text] [Related]
10. p53-upregulated-modulator-of-apoptosis (PUMA) deficiency affects food intake but does not impact on body weight or glucose homeostasis in diet-induced obesity.
Litwak SA; Loh K; Stanley WJ; Pappas EG; Wali JA; Selck C; Strasser A; Thomas HE; Gurzov EN
Sci Rep; 2016 Apr; 6():23802. PubMed ID: 27033313
[TBL] [Abstract][Full Text] [Related]
11. Loss of SFRP4 Alters Body Size, Food Intake, and Energy Expenditure in Diet-Induced Obese Male Mice.
Mastaitis J; Eckersdorff M; Min S; Xin Y; Cavino K; Aglione J; Okamoto H; Na E; Stitt T; Dominguez MG; Schmahl JP; Lin C; Gale NW; Valenzuela DM; Murphy AJ; Yancopoulos GD; Gromada J
Endocrinology; 2015 Dec; 156(12):4502-10. PubMed ID: 26406932
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity.
Smith KR; Hussain T; Karimian Azari E; Steiner JL; Ayala JE; Pratley RE; Kyriazis GA
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E688-E698. PubMed ID: 26884387
[TBL] [Abstract][Full Text] [Related]
13. Caloric Restriction Paradoxically Increases Adiposity in Mice With Genetically Reduced Insulin.
Dionne DA; Skovsø S; Templeman NM; Clee SM; Johnson JD
Endocrinology; 2016 Jul; 157(7):2724-34. PubMed ID: 27145011
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle-specific Cre recombinase expression, controlled by the human α-skeletal actin promoter, improves glucose tolerance in mice fed a high-fat diet.
Al Batran R; Gopal K; Martin MD; Ho KL; Almutairi M; Aburasayn H; Eaton F; Campbell JE; Ussher JR
Diabetologia; 2018 Aug; 61(8):1849-1855. PubMed ID: 29858650
[TBL] [Abstract][Full Text] [Related]
15. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
Guerre-Millo M; Rouault C; Poulain P; André J; Poitout V; Peters JM; Gonzalez FJ; Fruchart JC; Reach G; Staels B
Diabetes; 2001 Dec; 50(12):2809-14. PubMed ID: 11723064
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Ghrelin Exacerbates HFCS-Induced Adiposity and Insulin Resistance.
Ma X; Lin L; Yue J; Wu CS; Guo CA; Wang R; Yu KJ; Devaraj S; Murano P; Chen Z; Sun Y
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629187
[TBL] [Abstract][Full Text] [Related]
17. Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice.
DeBosch BJ; Chen Z; Finck BN; Chi M; Moley KH
Mol Endocrinol; 2013 Nov; 27(11):1887-96. PubMed ID: 24030250
[TBL] [Abstract][Full Text] [Related]
18. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
19. L-Arginine improves multiple physiological parameters in mice exposed to diet-induced metabolic disturbances.
Clemmensen C; Madsen AN; Smajilovic S; Holst B; Bräuner-Osborne H
Amino Acids; 2012 Sep; 43(3):1265-75. PubMed ID: 22200933
[TBL] [Abstract][Full Text] [Related]
20. PYY transgenic mice are protected against diet-induced and genetic obesity.
Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
